Accéder au contenu
Merck

HSP2MAG-63K

MILLIPLEX® Human Sepsis Panel

Configurable Human Sepsis 7-Plex Panel 2

Se connecter pour consulter les tarifs organisationnels et contractuels.

A propos de cet article

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000

Principaux documents

Voir toute la documentation
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Nom du produit

MILLIPLEX® Human Sepsis Panel,

species reactivity

human

Quality Level

200

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

accuracy: 87%
(MIP-1β), accuracy: 92%
(MIP-1α), accuracy: 95%
(Granzyme B), accuracy: 98%
(IL-8), standard curve range: 10-10,000 pg/mL
(IL-1α and MIP-1β), standard curve range: 195-200,000 pg/mL
(MMP-8), standard curve range: 2,930-3,000,000 pg/mL
(HSP70), standard curve range: 2-2,000 pg/mL
(Granzyme B), standard curve range: 5-5,000 pg/mL
(IL-8 and MIP-1β)

technique(s)

multiplexing: suitable

input

serum
cell culture supernatant

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

description

Configurable Human Sepsis 7-Plex Panel 2

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

General description

Sepsis or SIRS (systemic inflammatory response syndrome) results from infection, whether bacterial, viral, fungal, or parasitic. The pathogenesis of sepsis is very complex. Both an innate and acquired immune response to infection interrupts homeostasis with a shift of cytokine expression that increases immunosuppression. In addition, migration of the leukocytes in the inflamed tissues secretes a tissue factor leading to the formation of thrombin, also triggering the release of chemokines and adhesion molecules through endothelial cells. Severe sepsis occurs when hypotension or hypoperfusion to one or more organs leads to organ dysfunction, which, in turn, can cause septic shock, multiple organ dysfunction syndrome (MODS) and death.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 7 analytes in human serum, plasma, and cell culture supernatants.

Analytes included: Granzyme B, HSP70, IL-1α, IL-8, MIP-1α, MIP-1β, MMP-8

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

  • Immune Response Research Panel: Luminex® xMAP® platform simultaneously quantitates 7 critical immune response biomarkers (Granzyme B, HSP70, IL-1α, IL-8/CXCL8, MIP-1α/CCL3, MIP-1β/CCL4, MMP-8) for comprehensive sepsis immunology research.
  • Streamlined Sample Processing: Compatible with human serum, plasma, and cell/tissue culture supernatants using neat sample analysis - no dilution required, simplifying research protocols and minimizing sample handling errors.
  • Multi-Pathway Sepsis Research: Investigate cytotoxic T-cell responses (Granzyme B), cellular stress (HSP70), pro-inflammatory cytokines (IL-1α, IL-8), chemokine signaling (MIP-1α, MIP-1β), and tissue remodeling (MMP-8) in sepsis pathogenesis studies.
  • Comprehensive Immune Profiling: Simultaneously measure innate immune activation, adaptive immune responses, chemotactic signals, and tissue damage markers to understand complex sepsis immunopathology in research settings.
  • Translational Sepsis Research: Address critical research gaps in understanding sepsis progression from initial immune response through SIRS, severe sepsis, and potential progression to MODS in experimental studies.
  • Flexible Research Applications: Configure analyte selection for specific research questions and adapt to various experimental designs from mechanistic cell culture studies to clinical research sample analysis.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

Classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Numéro d'article de commerce international

RéférenceGTIN
HSP2MAG-63K-0704053252803369
HSP2MAG-63K-0604053252803352
HSP2MAG-63K-0304053252803321
HSP2MAG-63K-0504053252803345
HSP2MAG-63K-0204053252803314
HSP2MAG-63K-0404053252803338
HSP2MAG-63K-0104053252803307

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique